

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transport (GO:0015893) | 8.96307264 |
| 2 | organic cation transport (GO:0015695) | 8.69689733 |
| 3 | lysine metabolic process (GO:0006553) | 8.54305874 |
| 4 | lysine catabolic process (GO:0006554) | 8.54305874 |
| 5 | phosphate ion transport (GO:0006817) | 8.20094149 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.99838432 |
| 7 | quaternary ammonium group transport (GO:0015697) | 6.94709177 |
| 8 | phosphate ion transmembrane transport (GO:0035435) | 6.78391738 |
| 9 | cysteine metabolic process (GO:0006534) | 6.75040762 |
| 10 | exogenous drug catabolic process (GO:0042738) | 6.66944901 |
| 11 | drug catabolic process (GO:0042737) | 6.65082705 |
| 12 | response to mercury ion (GO:0046689) | 6.37986942 |
| 13 | tricarboxylic acid metabolic process (GO:0072350) | 6.11526199 |
| 14 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.93597502 |
| 15 | excretion (GO:0007588) | 5.88807101 |
| 16 | aspartate family amino acid catabolic process (GO:0009068) | 5.73167249 |
| 17 | short-chain fatty acid metabolic process (GO:0046459) | 5.55527525 |
| 18 | renal absorption (GO:0070293) | 5.44377992 |
| 19 | vitamin D metabolic process (GO:0042359) | 5.43474154 |
| 20 | branched-chain amino acid metabolic process (GO:0009081) | 5.37252941 |
| 21 | glutathione biosynthetic process (GO:0006750) | 5.31523942 |
| 22 | toxin transport (GO:1901998) | 5.30957346 |
| 23 | metanephric tubule development (GO:0072170) | 5.23991375 |
| 24 | metanephric nephron tubule development (GO:0072234) | 5.23991375 |
| 25 | phosphate ion homeostasis (GO:0055062) | 5.08571032 |
| 26 | trivalent inorganic anion homeostasis (GO:0072506) | 5.08571032 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04709162 |
| 28 | amino-acid betaine transport (GO:0015838) | 5.01775029 |
| 29 | carnitine transport (GO:0015879) | 5.01775029 |
| 30 | valine metabolic process (GO:0006573) | 4.98454905 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 4.94849973 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.94550670 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 4.94550670 |
| 34 | tryptophan catabolic process (GO:0006569) | 4.92236710 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 4.92236710 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 4.92236710 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.89268588 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 4.86733085 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.86733085 |
| 40 | metanephric nephron epithelium development (GO:0072243) | 4.81742041 |
| 41 | proline metabolic process (GO:0006560) | 4.81579887 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.79593500 |
| 43 | cellular modified amino acid catabolic process (GO:0042219) | 4.77824190 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 4.70431876 |
| 45 | modified amino acid transport (GO:0072337) | 4.69825412 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 4.69145329 |
| 47 | glycoside metabolic process (GO:0016137) | 4.67221437 |
| 48 | tryptophan metabolic process (GO:0006568) | 4.66004307 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.48885281 |
| 50 | metanephric epithelium development (GO:0072207) | 4.43049320 |
| 51 | fructose metabolic process (GO:0006000) | 4.39863939 |
| 52 | fatty acid beta-oxidation (GO:0006635) | 4.37121440 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 4.33591281 |
| 54 | peptide biosynthetic process (GO:0043043) | 4.28566700 |
| 55 | nephron tubule development (GO:0072080) | 4.18182782 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 4.15259696 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.13793542 |
| 58 | fatty acid oxidation (GO:0019395) | 4.07711628 |
| 59 | carnitine metabolic process (GO:0009437) | 4.07629286 |
| 60 | peptide catabolic process (GO:0043171) | 4.06795907 |
| 61 | response to phenylpropanoid (GO:0080184) | 4.05273245 |
| 62 | lipid oxidation (GO:0034440) | 4.00040743 |
| 63 | glutamate metabolic process (GO:0006536) | 3.98805054 |
| 64 | oligosaccharide catabolic process (GO:0009313) | 3.98348855 |
| 65 | serine family amino acid biosynthetic process (GO:0009070) | 3.89463092 |
| 66 | NADH metabolic process (GO:0006734) | 3.85755089 |
| 67 | sodium-independent organic anion transport (GO:0043252) | 3.85528077 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.82055595 |
| 69 | response to parathyroid hormone (GO:0071107) | 3.76607368 |
| 70 | response to growth hormone (GO:0060416) | 3.75846405 |
| 71 | indole-containing compound metabolic process (GO:0042430) | 3.71644623 |
| 72 | vitamin transport (GO:0051180) | 3.71129963 |
| 73 | renal tubule development (GO:0061326) | 3.70613768 |
| 74 | kynurenine metabolic process (GO:0070189) | 3.70612385 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.69608743 |
| 76 | glutathione metabolic process (GO:0006749) | 3.68374256 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 3.66082245 |
| 78 | fatty acid catabolic process (GO:0009062) | 3.60911186 |
| 79 | ketone body metabolic process (GO:1902224) | 3.56041739 |
| 80 | glutathione derivative biosynthetic process (GO:1901687) | 3.47337958 |
| 81 | glutathione derivative metabolic process (GO:1901685) | 3.47337958 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 3.47247779 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.46294838 |
| 84 | organic acid catabolic process (GO:0016054) | 3.46294838 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 3.45997654 |
| 86 | polyol transport (GO:0015791) | 3.42210591 |
| 87 | beta-amyloid metabolic process (GO:0050435) | 3.42066292 |
| 88 | monocarboxylic acid catabolic process (GO:0072329) | 3.39388490 |
| 89 | nephron epithelium development (GO:0072009) | 3.38702916 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.36267988 |
| 91 | drug metabolic process (GO:0017144) | 3.34361737 |
| 92 | dicarboxylic acid metabolic process (GO:0043648) | 3.34216017 |
| 93 | nephron epithelium morphogenesis (GO:0072088) | 3.34137817 |
| 94 | nephron tubule morphogenesis (GO:0072078) | 3.34137817 |
| 95 | tricarboxylic acid cycle (GO:0006099) | 3.31837058 |
| 96 | succinate metabolic process (GO:0006105) | 3.30958693 |
| 97 | biotin metabolic process (GO:0006768) | 3.30840020 |
| 98 | urate metabolic process (GO:0046415) | 10.6821322 |
| 99 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.6148259 |
| 100 | drug transmembrane transport (GO:0006855) | 10.5821518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38007610 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.37051206 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.50942408 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.32867309 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.87832942 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.70549533 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.93589251 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84186309 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.71005013 |
| 10 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.61553610 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57397097 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.43281418 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34898823 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31652070 |
| 15 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.25866921 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16951083 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15208116 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07985885 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03514179 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99654660 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88017839 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84008968 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82084593 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77974201 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.74405334 |
| 26 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.66245727 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.60731552 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55706722 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52574216 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.52366713 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48910213 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47165789 |
| 33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46971925 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46264540 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39776679 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35519158 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33963726 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.33540496 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29995851 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29308769 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19396142 |
| 42 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19374358 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18775946 |
| 44 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15519226 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14887300 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14887300 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10406664 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07531382 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03910989 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01884303 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00934310 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97917264 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95194683 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93485873 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93168421 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92028121 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91946145 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89427570 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88610963 |
| 60 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88490737 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87368488 |
| 62 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.86946087 |
| 63 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86591852 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86263297 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85170199 |
| 66 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84696992 |
| 67 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83854074 |
| 68 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.82726802 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82682399 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82571894 |
| 71 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.81782425 |
| 72 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80861415 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.79983139 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79517737 |
| 75 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78860113 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77165211 |
| 77 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76745110 |
| 78 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75022452 |
| 79 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.73553848 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73354402 |
| 81 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.71720358 |
| 82 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.71526212 |
| 83 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71280557 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 0.69755878 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69691154 |
| 86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69497360 |
| 87 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.69340670 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69239688 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.68998113 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68320509 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67997312 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67751513 |
| 93 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.66924300 |
| 94 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.66637648 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66594840 |
| 96 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.66552564 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.66210508 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.65571759 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.65518219 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64905234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.89832602 |
| 2 | MP0004043_abnormal_pH_regulation | 6.40272645 |
| 3 | MP0005332_abnormal_amino_acid | 5.03589706 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 5.02489955 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.91516094 |
| 6 | MP0003195_calcinosis | 4.02360120 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.01082700 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.98111991 |
| 9 | MP0001765_abnormal_ion_homeostasis | 3.84827581 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.16692640 |
| 11 | MP0001756_abnormal_urination | 3.09354979 |
| 12 | MP0002136_abnormal_kidney_physiology | 2.95398882 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.94458797 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.92874117 |
| 15 | MP0003878_abnormal_ear_physiology | 2.92874117 |
| 16 | MP0001958_emphysema | 2.67301571 |
| 17 | MP0003252_abnormal_bile_duct | 2.38006199 |
| 18 | MP0005365_abnormal_bile_salt | 2.30466029 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.17403214 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.16696100 |
| 21 | MP0003186_abnormal_redox_activity | 1.77541616 |
| 22 | MP0000538_abnormal_urinary_bladder | 1.72172123 |
| 23 | MP0008961_abnormal_basal_metabolism | 1.70547426 |
| 24 | MP0004885_abnormal_endolymph | 1.70121948 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65212087 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.48340394 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.38434583 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.38122850 |
| 29 | MP0005451_abnormal_body_composition | 1.34323329 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.30329294 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.29910553 |
| 32 | MP0002928_abnormal_bile_duct | 1.28947442 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.26007543 |
| 34 | MP0002168_other_aberrant_phenotype | 1.23193148 |
| 35 | MP0000230_abnormal_systemic_arterial | 1.18671438 |
| 36 | MP0005670_abnormal_white_adipose | 1.14407625 |
| 37 | MP0002135_abnormal_kidney_morphology | 1.09408051 |
| 38 | MP0005535_abnormal_body_temperature | 1.06348255 |
| 39 | MP0004147_increased_porphyrin_level | 1.03495533 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.01962906 |
| 41 | MP0003283_abnormal_digestive_organ | 1.00523178 |
| 42 | MP0002896_abnormal_bone_mineralization | 0.99961397 |
| 43 | MP0005666_abnormal_adipose_tissue | 0.97662988 |
| 44 | MP0001764_abnormal_homeostasis | 0.97599274 |
| 45 | MP0001666_abnormal_nutrient_absorption | 0.96829064 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 0.91294433 |
| 47 | MP0003172_abnormal_lysosome_physiology | 0.89888990 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 0.87961591 |
| 49 | MP0003646_muscle_fatigue | 0.82480398 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 0.82375313 |
| 51 | MP0003638_abnormal_response/metabolism_ | 0.80254450 |
| 52 | MP0001661_extended_life_span | 0.79710724 |
| 53 | MP0009642_abnormal_blood_homeostasis | 0.75633817 |
| 54 | MP0000747_muscle_weakness | 0.73132394 |
| 55 | MP0009764_decreased_sensitivity_to | 0.68644518 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 0.65946743 |
| 57 | MP0002796_impaired_skin_barrier | 0.64397283 |
| 58 | MP0005395_other_phenotype | 0.63843822 |
| 59 | MP0000371_diluted_coat_color | 0.62543285 |
| 60 | MP0010329_abnormal_lipoprotein_level | 0.62128645 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.62051851 |
| 62 | MP0000609_abnormal_liver_physiology | 0.61512209 |
| 63 | MP0001485_abnormal_pinna_reflex | 0.60559181 |
| 64 | MP0003959_abnormal_lean_body | 0.59067199 |
| 65 | MP0003879_abnormal_hair_cell | 0.58873253 |
| 66 | MP0003329_amyloid_beta_deposits | 0.53689349 |
| 67 | MP0008469_abnormal_protein_level | 0.53471816 |
| 68 | MP0002115_abnormal_skeleton_extremities | 0.51837199 |
| 69 | MP0000598_abnormal_liver_morphology | 0.51430034 |
| 70 | MP0004742_abnormal_vestibular_system | 0.50226434 |
| 71 | MP0005501_abnormal_skin_physiology | 0.49938153 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 0.48461447 |
| 73 | MP0005408_hypopigmentation | 0.47888848 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.47227379 |
| 75 | MP0003795_abnormal_bone_structure | 0.46671788 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.46661127 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.44622717 |
| 78 | MP0005165_increased_susceptibility_to | 0.44613670 |
| 79 | MP0003953_abnormal_hormone_level | 0.44349308 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.43791639 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.39953187 |
| 82 | MP0004858_abnormal_nervous_system | 0.39717762 |
| 83 | MP0000163_abnormal_cartilage_morphology | 0.38895668 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.37611734 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.35710026 |
| 86 | MP0004484_altered_response_of | 0.35546270 |
| 87 | MP0001663_abnormal_digestive_system | 0.35201445 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.34947758 |
| 89 | MP0004272_abnormal_basement_membrane | 0.34035191 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.33465103 |
| 91 | MP0009672_abnormal_birth_weight | 0.33376411 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.32929872 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.32828907 |
| 94 | MP0003724_increased_susceptibility_to | 0.31108609 |
| 95 | MP0001731_abnormal_postnatal_growth | 0.30486249 |
| 96 | MP0003315_abnormal_perineum_morphology | 0.29831535 |
| 97 | MP0001664_abnormal_digestion | 0.27142643 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.26134857 |
| 99 | MP0001177_atelectasis | 0.25960054 |
| 100 | MP0004233_abnormal_muscle_weight | 0.25029939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.63733078 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.23521145 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.18176409 |
| 4 | Gout (HP:0001997) | 6.93272853 |
| 5 | Hypomagnesemia (HP:0002917) | 6.87569860 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 6.69909713 |
| 7 | Polyuria (HP:0000103) | 6.53796145 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.18508320 |
| 9 | Abnormal urine output (HP:0012590) | 6.14814183 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.88268532 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.82493607 |
| 12 | Proximal tubulopathy (HP:0000114) | 5.50602321 |
| 13 | Polydipsia (HP:0001959) | 5.30247344 |
| 14 | Abnormal drinking behavior (HP:0030082) | 5.30247344 |
| 15 | Hyperuricemia (HP:0002149) | 5.05125907 |
| 16 | Increased purine levels (HP:0004368) | 5.05125907 |
| 17 | Hyperglycinuria (HP:0003108) | 4.77060979 |
| 18 | Tetany (HP:0001281) | 4.76341973 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.74076785 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 4.72581182 |
| 21 | Alkalosis (HP:0001948) | 4.71286793 |
| 22 | Renal salt wasting (HP:0000127) | 4.68215581 |
| 23 | Hyperaldosteronism (HP:0000859) | 4.60857988 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 4.47093719 |
| 25 | Generalized aminoaciduria (HP:0002909) | 4.17321005 |
| 26 | Hypercalciuria (HP:0002150) | 4.07741476 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.92645604 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92645604 |
| 29 | Ketoacidosis (HP:0001993) | 3.76108865 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 3.69233003 |
| 31 | Glycosuria (HP:0003076) | 3.69233003 |
| 32 | Renal tubular acidosis (HP:0001947) | 3.63814146 |
| 33 | Hypokalemia (HP:0002900) | 3.60925004 |
| 34 | Ketosis (HP:0001946) | 3.30942822 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29426669 |
| 36 | Hyperphosphaturia (HP:0003109) | 3.28466968 |
| 37 | Delayed epiphyseal ossification (HP:0002663) | 3.14897413 |
| 38 | Abnormal urine phosphate concentration (HP:0012599) | 3.10547135 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 3.05830772 |
| 40 | Hydroxyprolinuria (HP:0003080) | 3.05830772 |
| 41 | Abnormality of potassium homeostasis (HP:0011042) | 3.03799648 |
| 42 | Nephrocalcinosis (HP:0000121) | 3.01069457 |
| 43 | Nephrolithiasis (HP:0000787) | 2.84596806 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.79939213 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78811964 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.75770624 |
| 47 | Hypophosphatemia (HP:0002148) | 2.73617500 |
| 48 | Hyperglycinemia (HP:0002154) | 2.70691998 |
| 49 | Vascular calcification (HP:0004934) | 2.68059019 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.60269047 |
| 51 | Rickets (HP:0002748) | 2.57954858 |
| 52 | Metaphyseal cupping (HP:0003021) | 2.57945775 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.45798604 |
| 54 | Dehydration (HP:0001944) | 2.45502503 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.41690622 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41690622 |
| 57 | Hyperammonemia (HP:0001987) | 2.40543128 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.39052762 |
| 59 | Abnormality of sodium homeostasis (HP:0010931) | 2.35995952 |
| 60 | Hyponatremia (HP:0002902) | 2.32286973 |
| 61 | Metabolic acidosis (HP:0001942) | 2.30633654 |
| 62 | Vomiting (HP:0002013) | 2.28616646 |
| 63 | Abnormality of renal resorption (HP:0011038) | 2.27924325 |
| 64 | Enlarged kidneys (HP:0000105) | 2.26518735 |
| 65 | Renal tubular dysfunction (HP:0000124) | 2.23177654 |
| 66 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.22698915 |
| 67 | Confusion (HP:0001289) | 2.22340527 |
| 68 | Malnutrition (HP:0004395) | 2.18630806 |
| 69 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16443029 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.15889139 |
| 71 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11329756 |
| 72 | Adrenal overactivity (HP:0002717) | 2.10495099 |
| 73 | Thin bony cortex (HP:0002753) | 2.10268924 |
| 74 | Methylmalonic aciduria (HP:0012120) | 2.10111051 |
| 75 | Abnormal tarsal ossification (HP:0008369) | 2.03998837 |
| 76 | Lethargy (HP:0001254) | 2.03670220 |
| 77 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.02718239 |
| 78 | Tubular atrophy (HP:0000092) | 1.94695932 |
| 79 | Facial shape deformation (HP:0011334) | 1.93789282 |
| 80 | Potter facies (HP:0002009) | 1.93789282 |
| 81 | Tubulointerstitial fibrosis (HP:0005576) | 1.91738584 |
| 82 | Chondrocalcinosis (HP:0000934) | 1.89274644 |
| 83 | Lymphangioma (HP:0100764) | 1.89198899 |
| 84 | Bicornuate uterus (HP:0000813) | 1.86007393 |
| 85 | Abnormality of the costochondral junction (HP:0000919) | 1.82642333 |
| 86 | Nausea (HP:0002018) | 1.80539679 |
| 87 | Decreased circulating renin level (HP:0003351) | 1.79919837 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79244415 |
| 89 | Metaphyseal irregularity (HP:0003025) | 1.79166619 |
| 90 | Irritability (HP:0000737) | 1.78537621 |
| 91 | Abnormality of Sharpey fibers (HP:0100685) | 1.77934609 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 1.75973236 |
| 93 | Elevated alkaline phosphatase (HP:0003155) | 1.73465123 |
| 94 | Metaphyseal dysplasia (HP:0100255) | 1.72349304 |
| 95 | Glomerulosclerosis (HP:0000096) | 1.68672428 |
| 96 | Abnormality of serum amino acid levels (HP:0003112) | 1.68662253 |
| 97 | Neonatal onset (HP:0003623) | 1.66704385 |
| 98 | Tachypnea (HP:0002789) | 1.65202750 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 1.64025145 |
| 100 | Hypotension (HP:0002615) | 1.62815662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.07671823 |
| 2 | WNK3 | 8.13372515 |
| 3 | OXSR1 | 7.43008671 |
| 4 | STK39 | 4.37818819 |
| 5 | BCKDK | 3.12155528 |
| 6 | STK38L | 2.59843336 |
| 7 | NEK1 | 2.14199749 |
| 8 | PDK4 | 2.07996324 |
| 9 | PDK3 | 2.07996324 |
| 10 | WNK1 | 2.02893717 |
| 11 | SGK223 | 1.87662763 |
| 12 | SGK494 | 1.87662763 |
| 13 | PDK2 | 1.48431296 |
| 14 | STK38 | 1.39283269 |
| 15 | MST1R | 1.19261376 |
| 16 | MST4 | 1.14916037 |
| 17 | SGK2 | 0.99022517 |
| 18 | SGK3 | 0.97596099 |
| 19 | LRRK2 | 0.96812169 |
| 20 | FGFR4 | 0.96665222 |
| 21 | PINK1 | 0.90963628 |
| 22 | GRK6 | 0.84303966 |
| 23 | EPHB1 | 0.78833763 |
| 24 | GSK3A | 0.73588806 |
| 25 | MAP3K7 | 0.64719393 |
| 26 | SGK1 | 0.60904914 |
| 27 | DYRK1B | 0.59067069 |
| 28 | PTK2 | 0.56073996 |
| 29 | TIE1 | 0.55003442 |
| 30 | MAP3K3 | 0.49287986 |
| 31 | PRKAA1 | 0.48686150 |
| 32 | PAK4 | 0.48252533 |
| 33 | TGFBR2 | 0.48244006 |
| 34 | ABL2 | 0.47975391 |
| 35 | PDPK1 | 0.45112675 |
| 36 | MAPK11 | 0.45013998 |
| 37 | ERN1 | 0.40415494 |
| 38 | PTK6 | 0.40341462 |
| 39 | PRKCI | 0.37291127 |
| 40 | TRIB3 | 0.35897875 |
| 41 | PRKAA2 | 0.35101649 |
| 42 | INSRR | 0.34664855 |
| 43 | PAK3 | 0.34045832 |
| 44 | MET | 0.32398010 |
| 45 | PRKCZ | 0.31218427 |
| 46 | STK10 | 0.31126987 |
| 47 | PRKD2 | 0.31061731 |
| 48 | FER | 0.30858938 |
| 49 | PDK1 | 0.30271546 |
| 50 | PTK2B | 0.29960126 |
| 51 | IRAK2 | 0.27091318 |
| 52 | STK11 | 0.26304885 |
| 53 | NTRK1 | 0.23138718 |
| 54 | NME2 | 0.22667118 |
| 55 | PRKCD | 0.22509623 |
| 56 | MYLK | 0.21525648 |
| 57 | RIPK1 | 0.21085348 |
| 58 | MINK1 | 0.19423437 |
| 59 | PRKACG | 0.19345367 |
| 60 | EPHA4 | 0.19293317 |
| 61 | MAP3K14 | 0.18910713 |
| 62 | FRK | 0.18620591 |
| 63 | MAP3K2 | 0.16864780 |
| 64 | PRKCH | 0.16518067 |
| 65 | MAPK15 | 0.16280183 |
| 66 | IRAK3 | 0.15962755 |
| 67 | LATS1 | 0.15300036 |
| 68 | AKT2 | 0.15005867 |
| 69 | PRKCA | 0.13339499 |
| 70 | MAP2K3 | 0.13109863 |
| 71 | ERBB4 | 0.13098614 |
| 72 | IRAK1 | 0.12968415 |
| 73 | BMX | 0.12370016 |
| 74 | JAK2 | 0.11966591 |
| 75 | PRKACA | 0.11028547 |
| 76 | MAP2K4 | 0.10751202 |
| 77 | PIM1 | 0.10348171 |
| 78 | MAPK12 | 0.07345112 |
| 79 | PRKCG | 0.06845887 |
| 80 | ROCK1 | 0.05970294 |
| 81 | MAP3K11 | 0.05451912 |
| 82 | INSR | 0.05356531 |
| 83 | SCYL2 | 0.04907466 |
| 84 | NME1 | 0.02885466 |
| 85 | SRC | 0.02841816 |
| 86 | PRKCQ | 0.02662648 |
| 87 | MTOR | 0.00921041 |
| 88 | RPS6KA3 | 0.00096850 |
| 89 | CAMK4 | 0.00073386 |
| 90 | CAMK1G | -0.0424300 |
| 91 | ITK | -0.0400590 |
| 92 | ABL1 | -0.0368362 |
| 93 | DAPK2 | -0.0299030 |
| 94 | MAPK4 | -0.0263773 |
| 95 | TAOK1 | -0.0219789 |
| 96 | PRKD3 | -0.0197271 |
| 97 | CSNK1A1 | -0.0093772 |
| 98 | PRKACB | -0.0079344 |
| 99 | CSK | -0.0067552 |
| 100 | IGF1R | -0.0024996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.88556968 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.79031475 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.59783802 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.41975548 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30555362 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.22452497 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.15231943 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.09151056 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.92322999 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.83624542 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.53396479 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.49260139 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41862965 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30272549 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.23723072 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.19000305 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.07900662 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06471487 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01041346 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97877620 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88829693 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77005882 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73216938 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67693424 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.62850013 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.59020665 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57030055 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56086962 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44555253 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30909065 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.29869445 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.23883371 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21921715 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.19201676 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18541561 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13632955 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12261325 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12239120 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10398363 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07072454 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04970153 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03942443 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01826646 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99937677 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98792988 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96585566 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90814959 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90119257 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89931886 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88204858 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84105970 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75021846 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72320151 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68096156 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68072660 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65408452 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.64850448 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63681891 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60510243 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59635413 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58231823 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57310514 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55696137 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53669579 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53185663 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51569698 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45427861 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41649704 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41148727 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34285856 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33593713 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31186652 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30140065 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28297065 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28186727 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27941371 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23745271 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21347606 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21213801 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20641385 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.19946325 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18463254 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15234356 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14069396 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13677933 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11604129 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10890725 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.06086043 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05684128 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.05154449 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04404284 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.04117507 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.00346766 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00268732 |
| 95 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.1001319 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | -0.0707548 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0477355 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0461302 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0424175 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0304406 |

